Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial von Kelley, Robin Kate, Rimassa, Lorenza, Cheng, Ann-Lii, Kaseb, Ahmed, Qin, Shukui, Zhu, Andrew X, Chan, Stephen L, Melkadze, Tamar, Sukeepaisarnjaroen, Wattana, Breder, Valery, Verset, Gontran, Gane, Edward, Borbath, Ivan, Rangel, Jose David Gomez, Ryoo, Baek-Yeol, Makharadze, Tamta, Merle, Philippe, Benzaghou, Fawzi, Banerjee, Kamalika, Hazra, Saswati, Fawcett, Jonathan, Yau, Thomas

Volltext

Liposomal irinotecan plus fluorouracil and leucovorin versus fluorouracil and leucovorin for metastatic biliary tract cancer after progression on gemcitabine plus cisplatin (NIFTY)... von Yoo, Changhoon, Kim, Kyu-pyo, Jeong, Jae Ho, Kim, Ilhwan, Kang, Myoung Joo, Cheon, Jaekyung, Kang, Byung Woog, Ryu, Hyewon, Lee, Ji Sung, Kim, Kyung Won, Abou-Alfa, Ghassan K, Ryoo, Baek-Yeol

Volltext

Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study von Lee, Michael S, Ryoo, Baek-Yeol, Hsu, Chih-Hung, Numata, Kazushi, Stein, Stacey, Verret, Wendy, Hack, Stephen P, Spahn, Jessica, Liu, Bo, Abdullah, Heba, Wang, Yulei, He, Aiwu Ruth, Lee, Kyung-Hun, Bang, Y-J, Bendell, J, Chao, Y, Chen, J-S, Chung, H C, Davis, S L, Dev, A, Gane, E, George, B, He, A R, Hochster, H, Hsu, C-H, Ikeda, M, Lee, J, Lee, M, Mahipal, A, Manji, G, Morimoto, M, Numata, K, Pishvaian, M, Qin, S, Ryan, D, Ryoo, B-Y, Sasahira, N, Stein, S, Strickler, J, Tebbutt, N

Volltext

Association between treatment‐emergent hypertension and survival with lenvatinib treatment for patients with hepatocellular carcinoma in the REFLECT study von Piscaglia, Fabio, Ikeda, Kenji, Cheng, Ann‐Lii, Kudo, Masatoshi, Ikeda, Masafumi, Breder, Valery, Ryoo, Baek‐Yeol, Mody, Kalgi, Ren, Min, Ramji, Zahra, Sung, Max W.

Volltext

Loss of HER2 positivity after anti-HER2 chemotherapy in HER2-positive gastric cancer patients: results of the GASTric cancer HER2 reassessment study 3 (GASTHER3) von Seo, Seyoung, Ryu, Min-Hee, Park, Young Soo, Ahn, Ji Yong, Park, Yangsoon, Park, Sook Ryun, Ryoo, Baek-Yeol, Lee, Gin Hyug, Jung, Hwoon-Young, Kang, Yoon-Koo

Volltext

Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-bli... von Zhu, Andrew X, Dr, Park, Joon Oh, MD, Ryoo, Baek-Yeol, MD, Yen, Chia-Jui, MD, Poon, Ronnie, MD, Pastorelli, Davide, MD, Blanc, Jean-Frederic, MD, Chung, Hyun Cheol, MD, Baron, Ari D, MD, Pfiffer, Tulio Eduardo Flesch, MD, Okusaka, Takuji, MD, Kubackova, Katerina, MD, Trojan, Jorg, MD, Sastre, Javier, PhD, Chau, Ian, MD, Chang, Shao-Chun, MD, Abada, Paolo B, MD, Yang, Ling, MS, Schwartz, Jonathan D, MD, Kudo, Masatoshi, MD

Volltext

Regorafenib in patients with advanced Child‐Pugh B hepatocellular carcinoma: A multicentre retrospective study von Kim, Hyung‐Don, Bang, Yeonghak, Lee, Myung Ah, Kim, Jin Won, Kim, Jee Hyun, Chon, Hong Jae, Kang, Beodeul, Kang, Myoung Joo, Kim, Ilhwan, Cheon, Jaekyung, Hwang, Jun‐Eul, Kang, Jung Hun, Byeon, Seonggyu, Hong, Jung Yong, Ryoo, Baek‐Yeol, Lim, Ho Yeong, Yoo, Changhoon

Volltext

Clinical outcomes of systemic therapy in patients with unresectable or metastatic combined hepatocellular‐cholangiocarcinoma von Kim, Eo Jin, Yoo, Changhoon, Kang, Hyo Jeong, Kim, Kyu‐Pyo, Ryu, Min‐Hee, Park, Sook Ryun, Lee, Danbi, Choi, Jonggi, Shim, Ju Hyun, Kim, Kang Mo, Lim, Young‐Suk, Lee, Han Chu, Ryoo, Baek‐Yeol

Volltext

An Open‐Label, Multicenter, Phase I, Dose Escalation Study with Phase II Expansion Cohort to Determine the Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Intraveno... von El Dika, Imane, Lim, Ho Yeong, Yong, Wei Peng, Lin, Chia‐Chi, Yoon, Jung‐Hwan, Modiano, Manuel, Freilich, Bradley, Choi, Hye Jin, Chao, Tsu‐Yi, Kelley, Robin K., Brown, Joanne, Knox, Jennifer, Ryoo, Baek‐Yeol, Yau, Thomas, Abou‐Alfa, Ghassan K.

Volltext

Health‐related quality‐of‐life impact of pembrolizumab versus best supportive care in previously systemically treated patients with advanced hepatocellular carcinoma: KEYNOTE‐240... von Ryoo, Baek‐Yeol, Merle, Philippe, Kulkarni, Amit S., Cheng, Ann‐Lii, Bouattour, Mohamed, Lim, Ho Yeong, Breder, Valeriy, Edeline, Julien, Chao, Yee, Ogasawara, Sadahisa, Yau, Thomas, Garrido, Marcelo, Chan, Stephen L., Daniele, Bruno, Norquist, Josephine M., Chen, Erluo, Siegel, Abby B., Zhu, Andrew X., Finn, Richard S., Kudo, Masatoshi

Volltext

Kinetics of the neutrophil‐lymphocyte ratio during PD‐1 inhibition as a prognostic factor in advanced hepatocellular carcinoma von Choi, Won‐Mook, Kim, Ji Yoon, Choi, Jonggi, Lee, Danbi, Shim, Ju Hyun, Lim, Young‐Suk, Lee, Han Chu, Yoo, Changhoon, Ryu, Min‐Hee, Ryoo, Baek‐Yeol, Kim, Kang Mo

Volltext

Neoadjuvant modified FOLFIRINOX followed by postoperative gemcitabine in borderline resectable pancreatic adenocarcinoma: a Phase 2 study for clinical and biomarker analysis von Yoo, Changhoon, Lee, Sang Soo, Song, Ki Byung, Jeong, Jae Ho, Hyung, Jaewon, Park, Do Hyun, Song, Tae Jun, Seo, Dong Wan, Lee, Sung Koo, Kim, Myung-Hwan, Lee, Seung Soo, Kim, Jin Hee, Jin, Hyung-seung, Park, Jin-hong, Hwang, Dae Wook, Lee, Jae Hoon, Lee, Woohyung, Chang, Heung-Moon, Kim, Kyu-pyo, Ryoo, Baek-Yeol, Kim, Song Cheol

Volltext

Randomised Phase 1b/2 trial of tepotinib vs sorafenib in Asian patients with advanced hepatocellular carcinoma with MET overexpression von Ryoo, Baek-Yeol, Cheng, Ann-Li, Ren, Zhenggang, Kim, Tae-You, Pan, Hongming, Rau, Kun-Ming, Choi, Hye Jin, Park, Joong-Won, Kim, Jee Hyun, Yen, Chia Jui, Lim, Ho Yeong, Zhou, Dongli, Straub, Josef, Scheele, Juergen, Berghoff, Karin, Qin, Shukui

Volltext

Nab-paclitaxel plus gemcitabine versus FOLFIRINOX as the first-line chemotherapy for patients with metastatic pancreatic cancer: retrospective analysis von Kang, Jihoon, Hwang, Inhwan, Yoo, Changhoon, Kim, Kyu-pyo, Jeong, Jae Ho, Chang, Heung-Moon, Lee, Sang Soo, Park, Do Hyun, Song, Tae Jun, Seo, Dong Wan, Lee, Sung Koo, Kim, Myung-Hwan, Hong, Seung-Mo, Shin, Sang Hyun, Hwang, Dae Wook, Song, Ki Byung, Lee, Jae Hoon, Kim, Song Cheol, Ryoo, Baek-Yeol

Volltext

Real-world data analysis of patients with cancer of unknown primary von Kang, Sora, Jeong, Jae Ho, Yoon, Shinkyo, Yoo, Changhoon, Kim, Kyu-pyo, Cho, Hyungwoo, Ryoo, Baek-Yeol, Jung, Jinhong, Kim, Jeong Eun

Volltext

Regorafenib in previously treated advanced hepatocellular carcinoma: Impact of prior immunotherapy and adverse events von Yoo, Changhoon, Byeon, Seonggyu, Bang, Yeonghak, Cheon, Jaekyung, Kim, Jin W., Kim, Jee H., Chon, Hong J., Kang, Beodeul, Kang, Myoung J., Kim, Ilhwan, Hwang, Jun‐Eul, Kang, Jung H., Lee, Myung A., Hong, Jung Y., Lim, Ho Y., Ryoo, Baek‐Yeol

Volltext

Resumption of imatinib to control metastatic or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib (RIGHT): a randomised, placebo-controlled, pha... von Kang, Yoon-Koo, Prof, Ryu, Min-Hee, MD, Yoo, Changhoon, MD, Ryoo, Baek-Yeol, Prof, Kim, Hyun Jin, MD, Lee, Jong Jin, MD, Nam, Byung-Ho, PhD, Ramaiya, Nikhil, MBBS, Jagannathan, Jyothi, MD, Demetri, George D, Prof

Volltext

Somatostatin receptor 2 (SSTR2) expression is associated with better clinical outcome and prognosis in rectal neuroendocrine tumors von Kim, Joo Young, Kim, Jisup, Kim, Yong-il, Yang, Dong-Hoon, Yoo, Changhoon, Park, In Ja, Ryoo, Baek-Yeol, Ryu, Jin-Sook, Hong, Seung-Mo

Volltext

Genome-wide copy number alteration and VEGFA amplification of circulating cell-free DNA as a biomarker in advanced hepatocellular carcinoma patients treated with Sorafenib von Oh, Chung Ryul, Kong, Sun-Young, Im, Hyeon-Su, Kim, Hwa Jung, Kim, Min Kyeong, Yoon, Kyong-Ah, Cho, Eun-Hae, Jang, Ja-Hyun, Lee, Junnam, Kang, Jihoon, Park, Sook Ryun, Ryoo, Baek-Yeol

Volltext

Assessment of pegylated arginine deiminase and modified FOLFOX6 in patients with advanced hepatocellular carcinoma: Results of an international, single‐arm, phase 2 study von Harding, James J., Yang, Tsai‐Sheng, Chen, Yen‐Yang, Feng, Yin‐Hsun, Yen, Chia‐Jui, Ho, Ching‐Liang, Huang, Wen‐Tsung, El Dika, Imane, Akce, Mehmet, Tan, Benjamin, Cohen, Stacey A., Meyer, Timothy, Sarker, Debashis, Lee, Dae‐Won, Ryoo, Baek‐Yeol, Lim, Ho Yeong, Johnston, Amanda, Bomalaski, John S., O’Reilly, Eileen M., Qin, Shukui, Abou‐Alfa, Ghassan K.

Volltext